149 related articles for article (PubMed ID: 2427828)
1. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
Duff HJ; Gault NJ
J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
[TBL] [Abstract][Full Text] [Related]
2. Mexiletine-quinidine in isolated hearts: an interaction involving the sodium channel.
Duff HJ; Cannon NJ; Sheldon RS
Cardiovasc Res; 1989 Jul; 23(7):584-92. PubMed ID: 2557155
[TBL] [Abstract][Full Text] [Related]
3. Electropharmacologic synergism with mexiletine and quinidine.
Duff HJ; Kolodgie FD; Roden DM; Woosley RL
J Cardiovasc Pharmacol; 1986; 8(4):840-6. PubMed ID: 2427827
[TBL] [Abstract][Full Text] [Related]
4. Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.
Duff HJ; Rahmberg M; Sheldon RS
J Cardiovasc Pharmacol; 1990 Nov; 16(5):685-92. PubMed ID: 1703588
[TBL] [Abstract][Full Text] [Related]
5. Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
Duff HJ
J Pharmacol Exp Ther; 1989 May; 249(2):617-22. PubMed ID: 2724143
[TBL] [Abstract][Full Text] [Related]
6. Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacy.
Duff HJ; Mitchell LB; Wyse DG; Gillis AM; Sheldon RS
Clin Invest Med; 1991 Oct; 14(5):476-83. PubMed ID: 1660369
[TBL] [Abstract][Full Text] [Related]
7. Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans.
Duff HJ; Mitchell LB; Manyari D; Wyse DG
J Am Coll Cardiol; 1987 Nov; 10(5):1149-56. PubMed ID: 3668109
[TBL] [Abstract][Full Text] [Related]
8. [Impact of late sodium current inhibition on cardiac electrophysiology parameters and ventricular arrhythmias in isolated Langendorff perfused rabbit hearts with short QT interval].
Huang YW; Chen Y; Wang CY; Wu L
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Nov; 50(11):1087-1093. PubMed ID: 36418277
[No Abstract] [Full Text] [Related]
9. Quinidine for ventricular arrhythmias: value of electrophysiologic testing.
DiMarco JP; Garan H; Ruskin JN
Am J Cardiol; 1983 Jan; 51(1):90-5. PubMed ID: 6849270
[TBL] [Abstract][Full Text] [Related]
10. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
11. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
Costard-Jäckle A; Franz MR
J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
Kim SG; Felder SD; Waspe LE; Fisher JD
Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
[TBL] [Abstract][Full Text] [Related]
14. Effects of antiarrhythmics on the electrical restitution in perfused guinea-pig heart are critically determined by the applied cardiac pacing protocol.
Osadchii OE
Exp Physiol; 2019 Apr; 104(4):490-504. PubMed ID: 30758086
[TBL] [Abstract][Full Text] [Related]
15. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
[TBL] [Abstract][Full Text] [Related]
16. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
Roden DM; Iansmith DH; Woosley RL
J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
[TBL] [Abstract][Full Text] [Related]
17. Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo.
Costard-Jaeckle A; Liem LB; Franz MR
J Cardiovasc Pharmacol; 1989 Dec; 14(6):810-7. PubMed ID: 2481766
[TBL] [Abstract][Full Text] [Related]
18. Effects of simultaneous administration of mexiletine and quinidine on the electrophysiologic parameters of canine Purkinje fibers.
Burke GH; Loukides JE; Berman ND
J Cardiovasc Pharmacol; 1986; 8(6):1138-43. PubMed ID: 2434738
[TBL] [Abstract][Full Text] [Related]
19. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
Toivonen L; Kadish A; Morady F
Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed.
Bonavita GJ; Pires LA; Wagshal AB; Cuello C; Mittleman RS; Greene TO; Huang SK
Am Heart J; 1994 Apr; 127(4 Pt 1):847-51. PubMed ID: 8154423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
